Table 3.
Incremental Value of Metabolic Syndrome, C Reactive Protein, Adipocytokines or Homeostasis Model Assessment of Insulin Resistance in Predicting Coronary Calcium Scores beyond Established Risk Factors
Likelihood Ratio Test (χ2) | ||
---|---|---|
Variable Added to Model | Added to Full Model§ |
Added to Full Model with CRP and MetS |
Metabolic Syndrome | 6.78** | -- |
C Reactive Protein | 2.05 | -- |
Adiponectin | 0.52 | -- |
Adiponectin in men | 3.56 | -- |
Adiponectin in women | 0.24 | -- |
Resistin | 1.69 | -- |
Leptin | 11.4† | 6.87** |
HOMA-IR | 14.83† | 10.39† |
Interleukin-6 | 7.31** | 2.92 |
Soluble TNF Receptor 2 | 4.73* | 2.19 |
Tobit regression model of CAC data. All continuous variables were included in model as log transformed variables. Likelihood ratio test χ2 statistics and p values are reported for comparison of nested models when each metabolic variable was added to a full model containing established risk factors.
Full Model includes age, gender, race, 10 year Framingham Risk Score, family history, exercise, and medications (asa, statin, ace inhibitor). HOMA_IR = homeostasis model assessment of insulin resistance; MetS = metabolic syndrome; TNF = tumor necrosis factor.
p<0.05
p<0.01
p<0.001.